Search
for

    Sort by

    Research 121–150 of 1000+

    1. A 52-Week Real-Life Study of Baricitinib in Moderate to Severe Alopecia Areata: Clinical, Trichoscopic Assessment and Patient Reported Outcomes Journal of Clinical Medicine · 2025
    2. CLINICAL INSIGHTS FROM “A STUDY TO EVALUATE THE EFFICACY OF PIX LIQUIDA FOR INDIVIDUALS SUFFERING FROM ALOPECIA AREATA”: A CASE REPORT ˜The œBioscan. · 2025
    3. Updated Integrated Efficacy Analysis of Ritlecitinib Up to 3 Years in Adolescents With Alopecia Areata From the ALLEGRO Clinical Trials SKIN The Journal of Cutaneous Medicine · 2025
    4. Predictive Factors of Response and Real‐World Experience of Baricitinib on Alopecia Areata: A Single Tertiary Center Study on a 72 Patients' Cohort International Journal of Dermatology · 2025
    5. Rationale and Design of a Novel, Phase 3, External and Synthetic Placebo-Controlled Clinical Trial of Ritlecitinib 50 mg and 100 mg for Alopecia Areata Dermatology and Therapy · 2025
    6. Discontinuation and restart of Janus kinase inhibitors due to pregnancy in alopecia areata: a case series International Journal of Women’s Dermatology · 2025
    7. 0350 Impact of switching janus kinase inhibitors in the treatment of severe alopecia areata Journal of Investigative Dermatology · 2025
    8. Comparison of Efficacy of Oral Tofacitinib Versus Oral Minoxidil in Patients with Alopecia Areata Indus journal of bioscience research. · 2025
    9. Successful treatment of severe diffuse alopecia areata with abrocitinib Anais Brasileiros de Dermatologia · 2025
    10. Bempikibart shows its potential for hair regrowth in alopecia areata 2025
    11. Characteristics and predictive values of super-responders in alopecia areata under tofacitinib treatment: A single-center retrospective study Clinical and Experimental Dermatology · 2025
    12. 5PSQ-117 Effectiveness of baricitinib in alopecia areata 2025
    13. Baricitinib Effectiveness in JAKi‐Naïve and Tofacitinib‐Exposed Patients: A Prospective Study in Alopecia Areata Dermatologic Therapy · 2025
    14. Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis Figshare · 2025
    15. Efficacy and safety of compound glycyrrhizin in patients with alopecia areata: a systematic review and meta-analysis Figshare · 2025
    16. Comparison of Efficacy of Autologous Platelet Rich Plasma Therapy With 5% Topical Minoxidil Spray in Treating Alopecia Areata: A Head-to-Head Assessment of Novel Approaches Cureus · 2024
    17. Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis Frontiers in pharmacology · 2024
    18. Real-World Assessment of Disease Characteristics and Clinical Outcomes in Alopecia Areata in a Global Noninterventional Observational Cohort (ADAAGIO) Skin · 2024
    19. Systemic Tofacitinib Treatment in Pediatric Patients with Resistant Alopecia Areata Dermatologic therapy · 2024
    20. Growth Factors and Microneedling in Alopecia Areata: A Narrative Review Skin appendage disorders · 2024
    21. Efficacy of Oral Apremilast in The Treatment of Alopecia Areata, at The Tertiary Care Hospital, Karachi Journal of health and rehabilitation research · 2023
    22. Upadacitinib for the treatment of alopecia areata – A case report 2023
    23. Sustained Scalp, Eyebrow, and Eyelash Hair Regrowth with Ritlecitinib Through Week 48 in Patients with Alopecia Areata: Post-Hoc Analysis of the ALLEGRO Phase 2b/3 Study SKIN The Journal of Cutaneous Medicine · 2023
    24. Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Treated With Baricitinib: An Update Through Week 152 From BRAVE-AA2 Skin · 2023
    25. Alopecia areata: Ritlecitinib generates substantial re-growth of scalp hair 2023
    26. Effectiveness of Tofacitinib in Pre-adolescent Alopecia Areata: A Retrospective Case Series and Literature Review Acta dermato-venereologica · 2023
    27. When to expect scalp hair regrowth during treatment of severe alopecia areata with baricitinib: insights from trajectories analyses of patients enrolled in two phase III trials British Journal of Dermatology · 2023
    28. Efficacy of mesalazine in children with moderate to severe alopecia areata: case series of 18 patients Anais Brasileiros de Dermatologia · 2023
    29. BH15 Efficacy and safety of baricitinib in the management of severe alopecia areata over a 6-month period: a real-world experience British Journal of Dermatology · 2023
    30. Treatment of moderate-to-severe alopecia areata in adolescents with baricitinib: A retrospective review of 29 patients Journal of The American Academy of Dermatology · 2023